REGISTER FOR
KEYNOTE & PITCH SESSION

B2B MEETINGS WITH JAPANESE COMPANIES

Deadline:

Tuesday, July 13, 2021

5:00 PM PDT

Please contact Japanese companies via the E-mail listed to arrange a meeting

Pitch Session

Thursday, July 15, 2021

Shinichi Miyake, Ph.D.

Senior Manager

Scouting group

E-mail

Astellas Innovation Management, LLC

Astellas Innovation Management (https://aim.astellas.com/en) plays an important role in identifying, evaluating and accessing early-stage innovations into Astellas through a number of partnerships and alliances with various external partners. Located in key Bio-Hubs in the Bay Area CA, Cambridge MA, Cambridge UK, as well as Tsukuba Japan, AIM has built and developed a strong network across academia and the healthcare sectors.

AIM is focused on 3 major elements to drive innovation across Astellas

(1) biology and pathophysiology driving disease processes

(2) different and unique therapeutic modality/technology

(3) disease of high unmet medical need

Our priorities are focused on those partners who can address these elements. Greater details with regard to priorities and areas of focus for Astellas can found in the following link.
(https://aim.astellas.com/en/our-focus)